# Crescent Biopharma, Inc. (GLYC)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $17.98 (+5.73%)

> Crescent Biopharma, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies in the pharmaceutical sector. It specializes in advancing treatments that address significant unmet medical needs, often targeting niche or rare diseases. The company’s pipeline and research efforts aim to bring novel drug candidates through clinical development stages to improve patient outcomes. Crescent Biopharma plays a role in the broader healthcare and life sciences industry by contributing to medical innovation and therapeutic advancements. Its presence in financial markets, including listing on the Frankfurt Stock Exchange, allows investors to track its progress and financial performance as it works toward enhancing treatment options in biomedicine.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/GLYC)